India Globalization Capital Inc reports a Return on Equity (ROE) of -106.98%.

What is IGC's dividend yield?

India Globalization Capital Inc offers a dividend yield of 0.00%.

What is IGC's Quality Score?

Our AI rates IGC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy IGC?

Our AI Timing Score for IGC is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does IGC belong to?

India Globalization Capital Inc is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange

India Globalization Capital Inc (IGC) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

IGC AI Analysis Summary

Our AI summary for IGC: India Globalization Capital Inc (NYSE MKT), Healthcare >> Biotechnology sector. The stock currently trades at ROE of -106.98%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

IGC

India Globalization Capital Inc

US:NYSE MKT STOCK Healthcare >> Biotechnology News 83

USD 0.25

0.00 (1.61%) Day Change

Watchlist Portfolio Compare Chart

0.14

D/E

-107.0%

ROE

-71.3%

ROA

0.00%

Div Yield

INDIA GLOBALIZATION CAPITAL INC
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 0.25 Price 0.00 (1.61%) Day Change	NEWS SCORE: 83

IGC, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	83
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.25
PBV / Sector	3.91 / 44,105.10
Earning Per Share	-0.07

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	0.09 M GREAT
Average 1W Daily Value	0.06 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

47%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-552.11 / 97.23
NPM Average (%) / Sector	-835.48 / -1,697.84
NPM Change Average (%) / Sector	-22.32 / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-71.29 / 185,260.64
ROA Average (%) / Sector	-87.74 / 36,684.64
ROA Change Average (%) / Sector	15.19 / 422,221.42 GOOD
ROE (%) / Sector	-106.98 / 243,761.81
ROE Average (%) / Sector	-118.55 / 48,758.38
ROE Change Average (%) / Sector	29.52 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

Registration Details

Analyze Date	2026-08-06 08:00:09
Symbol	IGC
Name	INDIA GLOBALIZATION CAPITAL INC
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	104.37 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	23.95 / 9,702.21

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 10224 Falls Road, Potomac, MD, United States, 20854

Phone: 301 983 0998

Website: https://igcpharma.com

Employees: 70

Sector: Healthcare >> Biotechnology

Description: IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.